Tryptophan Metabolism and Gut Microbiota Interactions

Tryptophan metabolism within the gut represents a nexus of host–microbial co-metabolism that influences physiological functions spanning immune regulation, barrier integrity, metabolic homeostasis and gut–brain communication. The host directs dietary tryptophan into the kynurenine pathway, supporting neuroactive and immunomodulatory compound synthesis, while gut bacteria convert tryptophan into numerous indolic derivatives, trace amines and aromatic acids. These microbial catabolites engage receptors such as the aryl hydrocarbon receptor or trace amine-associated receptor 1 on epithelial, immune and neural cells, thereby governing mucosal defence, systemic inflammation and metabolic signalling. Disruption of this metabolic dialogue is implicated in conditions including metabolic syndrome, inflammatory bowel diseases and neuropsychiatric disorders, highlighting opportunities for targeted nutritional or microbial interventions.

Research from Nature Portfolio

Recent studies have elucidated the dual role of microbial tryptophan derivatives in host metabolism and immunity. Ruminococcus gnavus-generated tryptamine and phenethylamine have been shown to impair insulin signalling through TAAR1–ERK activation in rodent and primate models, linking dysbiosis in irritable bowel syndrome with metabolic syndrome. Seminal research on microbial tryptophan catabolites reveals that indolic and kynurenine derivatives serve as ligands for the aryl hydrocarbon receptor, reinforcing epithelial barrier function and modulating mucosal immunity. These findings provide mechanistic insight into host–microbiota co-metabolism and identify promising targets for therapeutic modulation of metabolic and inflammatory disorders.

Tryptophan Metabolism and Gut Microbiota Interactions publication trend

The graph below shows the total number of articles in tryptophan metabolism and gut microbiota interactions across all publications each year (not limited to Nature Index journals).

Technical terms

Tryptophan: An essential aromatic amino acid obtained from the diet and metabolised via host and microbial pathways.

Indole: A bacterial catabolite of tryptophan produced by tryptophanase, involved in gut signalling and barrier modulation.

Tryptamine: A monoamine derived from microbial tryptophan metabolism that activates trace amine-associated receptor 1.

Phenethylamine: A microbial amine generated from aromatic amino acids that influences host metabolic and inflammatory pathways.

Aryl hydrocarbon receptor (AHR): A ligand-activated transcription factor responsive to tryptophan catabolites, regulating immunity and barrier integrity.

Trace amine-associated receptor 1 (TAAR1): A G-protein-coupled receptor sensitive to microbial amines, modulating metabolic and neurological signals.

Kynurenine pathway: The primary host metabolic route converting tryptophan into bioactive immunomodulatory and neuroactive compounds.

References

1. Gut microbiota-derived tryptamine and phenethylamine impair insulin sensitivity in metabolic syndrome and irritable bowel syndrome. Nature Communications (2023).
2. Microbial tryptophan catabolites in health and disease. Nature Communications (2018).
3. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism. Frontiers in Cellular and Infection Microbiology (2018).
4. Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells. BMC Microbiology (2020).
5. Intestinal microbiota-derived tryptophan metabolites are predictive of Ah receptor activity. Gut Microbes (2020).